Mucous and skin injuries such as mouth ulcers, skin wounds, vaginal dryness and vaginal infections are very common (1/6 world population/year is concerned) but currently there are no ideal treatment. This is obvious as such treatments require dual but contradictory activities of inhibiting the growth of microbial cells on one hand and stimulating the growth of human cells on the other hand. It is also practically impossible to associate two different molecules in the same drug.
An ideal treatment must have anti-bacterial, anti-fungal,and wound cleaning properties. It should not affect natural flora, should keep the wound or the mocosal surface humid, should not be toxic or irritant, should stimulate healing process, should not cause resistance, should have analgesic properties, should have a good taste and should be of natural origin if possible. VITROBIO found and patented in 1997 a natural substance having these properties.
This discovery allowed us to conceive and register in APRIL 2007 three new drugs as medical devices in Europe as the 1st specific treatment for oral aphthous stomatitis, vaginal dryness/infection/injuries/pH equilibrium and skin injuries.
Being a new generation of efficient, natural, safe & broad spectrum products with a unique mode of action, these products have a 20 years + life span.
Each product represent a market potential of 25 000 units per million population.
Key words
Pharmaceutical, Medical device, dermatological, genito urinary, oral health, registered product.
We are looking for 1 exclusive distributor in each country except for France, Belgium, Portugal, Iran, Greece, Algeria, & Tunisia where these products are already reserved for distribution by renowned pharmaceutical companies.
Complete dossiers available. All conditions negotiable.
VITROBIO is an ISO 13485 certified company, recipient of Best Research Institute award by the French Academy of Science.